OABI
OABI
NASDAQ · Life Sciences Tools & Services

Omniab Inc

$1.70
+0.05 (+3.03%)
As of Feb 8, 2:02 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 178.30M 184.39M 150.46M
Net Income 9.64M 10.85M 8.86M
EPS
Profit Margin 5.4% 5.9% 5.9%
Rev Growth +6.6% +2.4% +24.8%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 126.00M 119.74M 97.60M
Total Equity 195.09M 186.51M 185.21M
D/E Ratio 0.65 0.64 0.53
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 15.79M 16.49M 14.30M
Free Cash Flow 6.81M 4.93M 6.48M